TNF and atherosclerosis: In summary, the findings of this present study demonstrated that HGMB1 is a direct target gene of miR‐34c, and miR‐34c might be a novel therapeutic strategy in the management of atherosclerosis by suppressing the expression of HGMB1, as well as its downstream pro‐inflammatory factor such TNF‐a and NF‐kB.